CDC’s Division of Cancer Prevention and Control conducts and supports studies to reduce the burden of cancer and eliminate health disparities. CDC contributes data and scientific expertise on cancer prevention and risk behaviors, the quality and appropriate use of cancer screening, the cost and cost-effectiveness of cancer control programs, health and wellness after a cancer diagnosis, and efforts to advance health equity.
Among persons who died with cancer, 2.0% in 2020 and 2.4% in 2021 had COVID-19 listed as the underlying cause of death, with higher percentages during COVID-19 peaks and among persons who were older, male, Hispanic or Latino, non-Hispanic American Indian or Alaska Native, non-Hispanic Black or African American, or living with leukemia, lymphoma, or myeloma.
In 2020, the COVID-19 pandemic led to significant declines in cancer screening, including among women served by the National Breast and Cervical Cancer Early Detection Program. Some states maintained pre–COVID-19 screening volumes despite high COVID-19 test percent positivity.